ResearcherUniversity of Colorado AnschutzNo recent work listed

Christina M. Stuart

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9851-8486; OpenAlex author ID A5023329971. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2023: 1 paper

Papers 1

Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.05.008 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Toshitaka Sugawara · 1 shared paper, 2023 · strength 0.17
- Paper Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. DOI 10.1016/j.surg.2023.05.008 ↗
Christopher Hanyoung Lieu · 1 shared paper, 2023 · strength 0.17
- Paper Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. DOI 10.1016/j.surg.2023.05.008 ↗
Ana Gleisner · 1 shared paper, 2023 · strength 0.17
- Paper Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. DOI 10.1016/j.surg.2023.05.008 ↗
Robert Alexander Meguid · 1 shared paper, 2023 · strength 0.17
- Paper Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. DOI 10.1016/j.surg.2023.05.008 ↗
Marco Del Chiaro · 1 shared paper, 2023 · strength 0.17
- Paper Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. DOI 10.1016/j.surg.2023.05.008 ↗
Richard David Schulick · 1 shared paper, 2023 · strength 0.17
- Paper Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. DOI 10.1016/j.surg.2023.05.008 ↗
Wells A. Messersmith · 1 shared paper, 2023 · strength 0.17
- Paper Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. DOI 10.1016/j.surg.2023.05.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.